These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1780697)

  • 41. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
    Chen L; Zhang Y; Chen M; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
    Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
    Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
    Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
    Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum levels of the tumour-associated trypsin inhibitor in patients with endometriosis.
    Medl M; Ogris E; Peters-Engl C; Mierau M; Buxbaum P; Leodolter S
    Br J Obstet Gynaecol; 1997 Jan; 104(1):78-81. PubMed ID: 8988701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TATI (tumor associated trypsin inhibitor) and cancer antigen 125 (CA 125) in patients with early-stage endometrial cancer.
    Peters-Engl C; Buxbaum P; Ogris E; Sevelda P; Medl M
    Anticancer Res; 1998; 18(6B):4635-9. PubMed ID: 9891532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in serum tumor markers between colon and rectal cancer. Comparison of CA 242 and carcinoembryonic antigen.
    Carpelan-Holmström MA; Haglund CH; Roberts PJ
    Dis Colon Rectum; 1996 Jul; 39(7):799-805. PubMed ID: 8674374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis.
    Gadducci A; Ferdeghini M; Prontera C; Moretti L; Mariani G; Bianchi R; Fioretti P
    Gynecol Oncol; 1992 Feb; 44(2):147-54. PubMed ID: 1312052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA125) in patients with epithelial ovarian cancer.
    Peters-Engl C; Medl M; Ogris E; Leodolter S
    Anticancer Res; 1995; 15(6B):2727-30. PubMed ID: 8669854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Anticancer Res; 1995; 15(6B):2731-7. PubMed ID: 8669855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum TATI levels and clinical correlation in tumors of the head and neck.
    Rayo JI; Garcia-Talavera JR; Martin M; Muñoz A; Del Cañizo A
    Scand J Clin Lab Invest Suppl; 1991; 207():33-5. PubMed ID: 1780687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative analysis of cancer-associated antigen CA-195, CA 19-9 and carcinoembryonic antigen in diagnosis, follow-up and monitoring of response to chemotherapy in patients with gastrointestinal cancer.
    Kornek G; Depisch D; Temsch EM; Scheithauer W
    J Cancer Res Clin Oncol; 1991; 117(5):493-6. PubMed ID: 1890143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
    Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
    BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validation and comparison of tumor-associated trypsin inhibitor (TATI) immunoassays.
    Janeiro E; Guimarães J; Stenman UH; Catarino M; Itkonen O
    Clin Chim Acta; 2012 Aug; 413(15-16):1244-8. PubMed ID: 22507084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum carcinoembryonic antigen, cancer antigen 125, cancer antigen 15-3, squamous cell carcinoma, and tumor-associated trypsin inhibitor concentrations during healthy pregnancy.
    Schlageter MH; Larghero J; Cassinat B; Toubert ME; Borschneck C; Rain JD
    Clin Chem; 1998 Sep; 44(9):1995-8. PubMed ID: 9732993
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of TATI and CYFRA 21-1 in patients with head and neck squamous cell carcinoma.
    Goumas PD; Mastronikolis NS; Mastorakou AN; Vassilakos PJ; Nikiforidis GC
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(2):106-14. PubMed ID: 9166881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical studies of type-I procollagen carboxyterminal peptide in serum of patients with gastric cancer: comparison with CEA and CA19-9.
    Ogawa K; Naritaka Y; Katsube T; Ohtani Y; Yagawa H; Kajiwara T
    J Gastroenterol; 1994 Jun; 29(3):250-6. PubMed ID: 8061794
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Excretion of a tumor-associated trypsin inhibitor (TATI) in urine of patients with gynecological malignancy.
    Huhtala ML; Kahanpää K; Seppälä M; Halila H; Stenman UH
    Int J Cancer; 1983 Jun; 31(6):711-4. PubMed ID: 6190763
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Tumor markers in gastrointestinal cancer and its clinical significance].
    Taguchi T; Ota J; Sumida S; Rii M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3004-9. PubMed ID: 3479051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative evaluation of serum CA 195 and carcinoembryonic antigen in metastatic carcinoma.
    Verdi CJ; Ahmann FR; Schifman RB; Elvick AL; Ahmann ME; Marx PC
    Cancer; 1993 Jun; 71(11):3625-32. PubMed ID: 8490911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies.
    Frenette PS; Thirlwell MP; Trudeau M; Thomson DM; Joseph L; Shuster JS
    Tumour Biol; 1994; 15(5):247-54. PubMed ID: 7991985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.